Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort. (2016)

First Author: Willis MD

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/1352458515614092

PubMed Identifier: 26514979

Publication URI: http://europepmc.org/abstract/MED/26514979

Type: Journal Article/Review

Volume: 22

Parent Publication: Multiple sclerosis (Houndmills, Basingstoke, England)

Issue: 9

ISSN: 1352-4585